Hudson Edge Investment Partners’s Gilead Sciences GILD Stock Holding History

Hudson Edge Investment Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-3,875	Closed	-$323K	–	162
2016 Q2	$323K	Sell	3,875 -650	-14%	-$57.7K	0.05%	131
2016 Q1	$416K	Buy	4,525 +245	+6%	+$22.1K	0.04%	153
2015 Q4	$433K	Buy	4,280 +175	+4%	+$18.2K	0.04%	119
2015 Q3	$403K	Buy	4,105 +150	+4%	+$16.7K	0.02%	117
2015 Q2	$463K	Sell	3,955 -155	-4%	-$16.9K	0.02%	120
2015 Q1	$403K	Buy	+4,110	New	+$417K	0.02%	126

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hudson Edge Investment Partners's GILD Position: Q3 2016 in Review

Hudson Edge Investment Partners sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 3,875 shares — an estimated $323K sold.

Hudson Edge Investment Partners first reported a position in GILD in Q1 2015 and held it in 6 quarters. The position peaked at $463K in Q2 2015. 1,558 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

Hudson Edge Investment Partners reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
Hudson Edge Investment Partners sold 3,875 Gilead Sciences shares in Q3 2016, an estimated $323K.
Hudson Edge Investment Partners first reported a position in Gilead Sciences in Q1 2015 and held it in 6 quarters.
Hudson Edge Investment Partners's Gilead Sciences position peaked at $463K in Q2 2015.
1,558 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Hudson Edge Investment Partners's 13F filing for Q3 2016, filed 8 Nov 2016.